- Persistent suboptimal molecular response in a patient with chronic myelogenous leukemia and Klinefelter syndrome
-
Chakraborty R, Mukkamalla SKR, Singam K, Calderon N
- KMID: 2070143
- Korean J Intern Med.
- 2014 Nov;29(6):827-829.
- doi: 10.3904/kjim.2014.29.6.827
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Concomitant AID Expression and BCL7A Loss Associates With Accelerated Phase Progression and Imatinib Resistance in Chronic Myeloid Leukemia
-
Yu N, Shin S, Choi JR, Kim Y, Lee KA
- KMID: 2373641
- Ann Lab Med.
- 2017 Mar;37(2):177-179.
- doi: 10.3343/alm.2017.37.2.177
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Transformation into large-cell neuroendocrine carcinoma associated with acquired resistance to erlotinib in nonsmall cell lung cancer
-
Lim JU, Woo IS, Jung YH, Byeon JH, Park CK, Kim TJ, Kim HR
- KMID: 2070144
- Korean J Intern Med.
- 2014 Nov;29(6):830-833.
- doi: 10.3904/kjim.2014.29.6.830
No abstract available. -
- CITED
-
- Close
- SHARE
-
- Close
- Tofacitinib Prevents Radiographic Progression in Rheumatoid Arthritis
-
Kim JW, Choi IA, Lee EY, Song YW, Lee EB
- KMID: 1793016
- J Korean Med Sci.
- 2013 Aug;28(8):1134-1138.
- doi: 10.3346/jkms.2013.28.8.1134
Tofacitinib, a novel Janus kinase inhibitor, may prevent structural damage in rheumatoid arthritis (RA). In this cohort study, we compared radiographic progression of hand joints between 21 RA patients who... -
- CITED
-
- Close
- SHARE
-
- Close
- Guidelines for the management of myeloproliferative neoplasms
-
Choi CW, Bang SM, Jang S, Jung CW, Kim HJ, Kim HY, Kim SJ, Kim YK, Park J, Won JH
- KMID: 2381581
- Korean J Intern Med.
- 2015 Nov;30(6):771-788.
- doi: 10.3904/kjim.2015.30.6.771
Polycythemia vera, essential thrombocythemia, and primary myelofibrosis are collectively known as 'Philadelphia-negative classical myeloproliferative neoplasms (MPNs).' The discovery of new genetic aberrations such as Janus kinase 2 (JAK2) have enhanced... -
- CITED
-
- Close
- SHARE
-
- Close
- Post-Progression Survival in Patients with Non-Small Cell Lung Cancer with Clinically Acquired Resistance to Gefitinib
-
Kim H, Yun T, Lee YJ, Han JY, Kim HT, Lee GK
- KMID: 1777655
- J Korean Med Sci.
- 2013 Nov;28(11):1595-1602.
- doi: 10.3346/jkms.2013.28.11.1595
Most patients with tyrosine kinase inhibitor (TKI)-sensitive non-small cell lung cancer (NSCLC) eventually develop acquired resistance to TKIs. Factors that affect TKI-sensitive patient survival after progression during TKI treatment remain... -
- CITED
-
- Close
- SHARE
-
- Close
- Clinical efficacy of erlotinib, a salvage treatment for non-small cell lung cancer patients following gefitinib failure
-
Cho KM, Keam B, Kim TM, Lee SH, Kim DW, Heo DS
- KMID: 2381594
- Korean J Intern Med.
- 2015 Nov;30(6):891-898.
- doi: 10.3904/kjim.2015.30.6.891
BACKGROUND/AIMS: The purpose of this study was to identify predictive factors for erlotinib treatment in non-small cell lung cancer (NSCLC) patients following gefitinib failure. METHODS: Forty-five patients with NSCLC who were... -
- CITED
-
- Close
- SHARE
-
- Close
- Peptide Nucleic Acid Clamping and Direct Sequencing in the Detection of Oncogenic Alterations in Lung Cancer: Systematic Review and Meta-Analysis
-
Song JU, Lee J
- KMID: 2418783
- Yonsei Med J.
- 2018 Mar;59(2):211-218.
- doi: 10.3349/ymj.2018.59.2.211
PURPOSE: Molecular testing in non-small cell lung cancer (NSCLC) aids in identifying oncogenic alterations. The aim of this study was to compare the rates of detection of oncogenic alterations and... -
- CITED
-
- Close
- SHARE
-
- Close
- EGFR Polymorphism as a Predictor of Clinical Outcome in Advanced Lung Cancer Patients Treated with EGFR-TKI
-
Jung M, Cho BC, Lee CH, Park HS, Kang YA, Kim SK, Chang J, Kim DJ, Rha SY, Kim JH, Lee JH
- KMID: 1414254
- Yonsei Med J.
- 2012 Nov;53(6):1128-1135.
- doi: 10.3349/ymj.2012.53.6.1128
PURPOSE: Mutations in the epidermal growth factor receptor (EGFR) have been confirmed as predictors of the efficacy of treatment with EGFR-tyrosine kinase inhibitors (TKIs). We investigated whether polymorphisms of the... -
- CITED
-
- Close
- SHARE
-
- Close
- Long-Surviving Patients with Recurrent GIST after Receiving Cytoreductive Surgery with Imatinib Therapy
-
Choi WH, Kim S, Hyung WJ, Yu JS, Park CI, Choi SH, Noh SH
- KMID: 1758574
- Yonsei Med J.
- 2009 Jun;50(3):437-440.
- doi: 10.3349/ymj.2009.50.3.437
In the treatment of recurrent or metastatic gastrointestinal stromal tumors (GIST), good prognoses may not be expected by surgery alone. Recently, imatinib has been applied for the treatment of GISTs,... -
- CITED
-
- Close
- SHARE
-
- Close
